EcoSynthetix reports after the market closes on November 3. One analyst expects a small loss and lower revenue than a year ago. The company has missed EPS estimates in each of its last four comparable quarters with available results.
EcoSynthetix Inc. (TSX: ECO; ECO.TO) will report results for the quarter ended September 30, 2026, after the market closes on November 3. A conference call is scheduled for November 4.
Recent earnings trend
EcoSynthetix Inc
ECO.TO
ECO.TO
EcoSynthetix Inc
WealthAwesomeMarket cap
$83.47M
52W high
$5.02
52W low
$1.34
1W change
-14.97%
Beta
0.45
Analyst Price Targets
Based on analyst covering ECO · as of Sep 17, 2026
Wall Street analysts forecast ECO stock price to rise 490.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$8.39
+490.8% Upside
Current Price
C$1.42
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ECO's historical volatility
30-Day Vol
79.1%
Annualized
90-Day Vol
65.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.19
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.34 | C$1.02 – C$1.76 |
| 60 trading days | C$1.26 | C$0.86 – C$1.85 |
| 90 trading days | C$1.19 | C$0.74 – C$1.91 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-28 | -0.0101 | — | — |
| 2026-03-31 | 2026-05-07 | -0.0138 | — | — |
| 2025-12-31 | 2026-02-19 | 0.0036 | — | — |
| 2025-09-30 | 2025-11-06 | -0.0021 | — | — |
| 2025-06-30 | 2025-07-29 | 0.0026 | — | — |
| 2025-03-31 | 2025-05-08 | -0.0149 | — | — |
The calendar doesn’t list headline EPS figures. Available estimates from one analyst put EPS at -C$0.01 and revenue at C$4.14 million. With just one analyst contributing, these figures offer a limited view of expectations, not a broad consensus.
For Canadian investors, the report will show whether sales and losses are stabilizing after a weaker second quarter. EcoSynthetix reported US$4.5 million in Q2 net sales, down 9% from a year earlier, and an adjusted EBITDA loss of US$0.2 million. The company cited weaker demand in its end markets but also pointed to ongoing commercial trials, including one with a global top-five tissue producer.
Investor takeaway: The outlook is cautious. The one-analyst forecast calls for EPS of -C$0.01, unchanged from a year ago, and revenue of C$4.14 million, down 7.4%. EcoSynthetix has not beaten EPS estimates in its last four comparable quarters with available results and estimates. Investors will be watching for signs of stronger demand and progress in commercial trials. Keep in mind that one analyst’s forecast is not a broad consensus.
C$4.14 million
That’s the one-analyst revenue estimate for the September quarter, implying a 7.4% decline from a year earlier. The EPS estimate is -C$0.01, matching last year’s result. It hasn’t changed in the past 30 days.
Bull case
Revenue above the C$4.14 million estimate, or signs that commercial trials are moving toward wider adoption, could help offset recent weakness in demand. In its Q2 update, the company reported US$29.1 million in cash and term deposits, which provides context for its ability to fund operations and trials.
Bear case
The estimate already points to a 7.4% revenue decline, following weaker Q2 sales and an adjusted EBITDA loss. If demand remains soft, revenue could miss expectations and losses may continue. EcoSynthetix has missed EPS estimates in each of its last four comparable quarters with reported estimates and actual results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
